A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amneal Intermediate Inc
Free Cash Flow Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Free Cash Flow
$276.4m
CAGR 3-Years
-4%
CAGR 5-Years
13%
CAGR 10-Years
10%
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$20.7B
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$12.9B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
14%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$4.8B
CAGR 3-Years
-45%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$13.1B
CAGR 3-Years
34%
CAGR 5-Years
11%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Amneal Intermediate Inc's Free Cash Flow?
Free Cash Flow
276.4m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Free Cash Flow amounts to 276.4m USD.

What is Amneal Intermediate Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
10%

The average annual Free Cash Flow growth rates for Amneal Intermediate Inc have been -4% over the past three years , 13% over the past five years , and 10% over the past ten years .

Back to Top